Remtolumab (anti-IL-17A&TNF-alpha) is a dual-variable domain immunoglobulin that neutralises both tumor necrosis factor α (TNFα) and IL-17A. Remtolumab (anti-IL-17A&TNF-alpha) shows dual inhibition of TNFα and IL-17A. Remtolumab (anti-IL-17A&TNF-alpha) can be used for rheumatoid arthritis (RA) research.Purity≥ 90% (SDS-PAGE&SEC)Endotoxin Level≤ 1.0EU/mg
Specification: Carrier Free, ExactAb™, Low Endotoxin, Validated, Recombinant, Azide Free, ≥90%(SDS-PAGE&SEC), Lot by Lot
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB182807-SCI_384d8f8c0ec051ab27504f2039a28d0e.pdf
- UPC:
- 51386012
- Condition:
- New
- Availability:
- 5-10 days
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab182807-1mg
- CAS:
- 1791410-27-9
- Product Size:
- 1mg